Literature DB >> 164201

Hyperlipidaemia in children.

J K Lloyd.   

Abstract

Hyperlipidaemia in children is most commonly expressed as hypercholesterolaemia. "Normal values" for serum cholesterol, if defined statistically, vary between communities, and levels of cholesterol in childhood above which an increased risk of coronary heart disease in adult life may be expected have not been firmly established. It is suggested that serum cholesterol concentration over 250 mg/dl (6.47 mmol/l) in a child over 1 year of age merits detailed investigation, including full lipoprotein analysis, and levels of serum cholesterol between230 and 250 mg/dl (5.95-6.47 mmol/l) should be repeated with further studies if indicated. Secondary hyperlipoproteinaemia rarely presents diagnostic problems but must always be excluded. The only primary hyperlipoproteinaemia likely to be encountered in childhood is familial hyperbetalipoproteinaemia in its common heterozygous form. The most effective means to date of lowering serum cholesterol in this condition is cholestyramine, but the long-term consequences of therapy are not known and treatment should at present be limited to children from high-risk families. Long-term follow-up is essential and until results of such studies are available population screening is unjustified.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164201      PMCID: PMC484091          DOI: 10.1136/hrt.37.2.105

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  32 in total

1.  Pediatric familial type IV hyperlipoproteinemia.

Authors:  C J Glueck; R Tsang; R Fallat; S Ford; G Evans; D Beckett; P Steiner
Journal:  Trans Assoc Am Physicians       Date:  1972

2.  Use of cholestyramine in treatment of children with familial hypercholesterolaemia.

Authors:  R J West; J K Lloyd
Journal:  Arch Dis Child       Date:  1973-05       Impact factor: 3.791

3.  The identification of risk factors in normal children in the development of arteriosclerosis.

Authors:  A Drash; F Hengstenberg
Journal:  Ann Clin Lab Sci       Date:  1972 Sep-Oct       Impact factor: 1.256

4.  Ileal by-pass in the management of familial hypercholesterolaemia.

Authors:  I D Johnston; J A Davis; C D Moutafis; N B Myant
Journal:  Proc R Soc Med       Date:  1967-08

5.  Coronary artery disease in combat casualties in Vietnam.

Authors:  J J McNamara; M A Molot; J F Stremple; R T Cutting
Journal:  JAMA       Date:  1971-05-17       Impact factor: 56.272

6.  Cholestyramine and nicotinic acid in the treatment of familial hyperbetalipoproteinaemia in the homozygous form.

Authors:  C D Moutafis; N B Myant; M Mancini; P Oriente
Journal:  Atherosclerosis       Date:  1971 Sep-Oct       Impact factor: 5.162

7.  Sturucture of an abnormal plasma lipoprotein (LP-X) characterizing obstructive jaundice.

Authors:  D Seidel; B Agostini; P Müller
Journal:  Biochim Biophys Acta       Date:  1972-01-27

8.  Prospective study of serum cholesterol levels during first year of life.

Authors:  J M Darmady; A S Fosbrooke; J K Lloyd
Journal:  Br Med J       Date:  1972-06-17

9.  Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood.

Authors:  P O Kwiterovich; D S Fredrickson; R I Levy
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

10.  Cholesterol and the child: studies of the cholesterol levels of Busselton school children and their parents.

Authors:  R C Godfrey; N S Stenhouse; K J Cullen; V Blackman
Journal:  Aust Paediatr J       Date:  1972-04
View more
  5 in total

1.  Lipoprotein measurements--a necessity for precise assessment of risk in children from high-risk families.

Authors:  D Heldenberg; I Tamir; O Levtow; Y Burstein; B Werbin
Journal:  Arch Dis Child       Date:  1979-09       Impact factor: 3.791

2.  Primary hyperlipoproteinemia in childhood and adolescence: identification and treatment of persons at risk for premature atherosclerosis.

Authors:  V Rose; D M Allen; R G Pearse; J Chapell
Journal:  Can Med Assoc J       Date:  1976-10-23       Impact factor: 8.262

3.  Screening for familial hyper-beta-lipoproteinaemia in children in hospital.

Authors:  J V Leonard; A S Fosbrooke; J K Lloyd; O H Wolff
Journal:  Arch Dis Child       Date:  1976-11       Impact factor: 3.791

Review 4.  Special Considerations for Lipid-Lowering Therapy in Women Reflecting Recent Randomized Trials.

Authors:  Anandita Agarwala; Anne Goldberg
Journal:  Curr Atheroscler Rep       Date:  2021-06-19       Impact factor: 5.113

Review 5.  Dyslipidemia in women: etiology and management.

Authors:  Binh An P Phan; Peter P Toth
Journal:  Int J Womens Health       Date:  2014-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.